Yahya El Mir: Ziwig Biotech Achieves U.S. Certification for Endometriosis Saliva Test – The Business Journal
The Business Journal shared a post on LinkedIn:
” [HEALTH] Ziwig Biotech Achieves U.S. Certification for Endometriosis Saliva Test.
One year after its deployment in France, the Lyon-based biotech (100 employees) will launch its test in the United States.
The product: ‘Ziwig Endotest‘, the first saliva test for the early diagnosis of endometriosis, which affects between 10 and 15% of women of childbearing age worldwide.
A flawless run in France:
- Reimbursed by the Health Insurance (~800€/test)
- 100 partner expert centres
- 22,500 patients benefiting in 2026
The test was awarded the Prix Galien International 2024 in the ‘Best Medical Technology’ category.
Partnership imminent: ‘We are conducting negotiations with several major laboratories. An agreement should be signed in the coming weeks,’ says Yahya EL MIR, founder.
Next stop: Germany.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 12, 2026, 14:29Fahima Hussain: When Reproductive Trauma Goes Unspoken
-
Mar 12, 2026, 12:56Vinnie Arvin Amir: New AI Study Explores Immune Factors in Pregnancy Loss
-
Mar 12, 2026, 12:53Deep Learning Bridges the Diagnostic Gap in Chronic Endometritis – Medicina MDPI
-
Mar 12, 2026, 12:49Explore the ASRM CELL Training Lab – ASRM
-
Mar 12, 2026, 02:28Anthony Griffiths to Discuss Multidisciplinary Approaches to Endometriosis Care – BSGI
-
Mar 11, 2026, 12:36Christopher Robinson: B-Lynch Uterine Compression Technique Discussed in AJOG Expert Review
-
Mar 11, 2026, 09:55Abstract Deadline and Early Registration Approaching for ESHRE Embryology 2026 – ESHRE
-
Mar 11, 2026, 08:57How Hyaluronic Acid Medium Improves Live Birth Rate? – RBMO
-
Mar 11, 2026, 08:46PCOS and Higher BMI Linked to Increased Risk of Type 2 Diabetes – Fertility and Sterility